Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

1.

The AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) trial: to believe or not to believe?

Nicholls SJ.

J Am Coll Cardiol. 2012 Jun 5;59(23):2065-7. doi: 10.1016/j.jacc.2012.02.021. Epub 2012 Apr 18. No abstract available.

PMID:
22520248
[PubMed - indexed for MEDLINE]
Free Article
2.
3.

Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.

Cziraky MJ, Watson KE, Talbert RL.

J Manag Care Pharm. 2008 Oct;14(8 Suppl):S3-28; quiz S30-1. Review.

PMID:
19891279
[PubMed - indexed for MEDLINE]
Free Article
4.
5.

Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.

Abdel-Maksoud M, Sazonov V, Gutkin SW, Hokanson JE.

J Cardiovasc Pharmacol. 2008 Apr;51(4):331-51. doi: 10.1097/FJC.0b013e318165e2e7. Review.

PMID:
18427276
[PubMed - indexed for MEDLINE]
6.

Is niacin ineffective? Or did AIM-HIGH miss its target?

Nicholls SJ.

Cleve Clin J Med. 2012 Jan;79(1):38-43. doi: 10.3949/ccjm.79a.11166.

PMID:
22219232
[PubMed - indexed for MEDLINE]
Free Article
7.

Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.

Nesto RW.

Am J Cardiovasc Drugs. 2005;5(6):379-87. Review.

PMID:
16259526
[PubMed - indexed for MEDLINE]
8.

The significance of low HDL-cholesterol levels in an ageing society at increased risk for cardiovascular disease.

Windler E, Schöffauer M, Zyriax BC.

Diab Vasc Dis Res. 2007 Jun;4(2):136-42. Review.

PMID:
17654448
[PubMed - indexed for MEDLINE]
Free Article
9.

High-density lipoprotein particles, coronary heart disease, and niacin.

Asztalos BF.

J Clin Lipidol. 2010 Sep-Oct;4(5):405-10. doi: 10.1016/j.jacl.2010.08.012. Epub 2010 Aug 19.

PMID:
21122684
[PubMed - indexed for MEDLINE]
10.

Combination niacin and statin therapy in primary and secondary prevention of cardiovascular disease.

Levy DR, Pearson TA.

Clin Cardiol. 2005 Jul;28(7):317-20. Review.

PMID:
16075823
[PubMed - indexed for MEDLINE]
11.

Diabetic dyslipidemia: a practical guide to therapy.

Tovar JM, Bazaldua OV, Loffredo A.

J Fam Pract. 2008 Jun;57(6):377-88.

PMID:
18544321
[PubMed - indexed for MEDLINE]
12.

The surprising AIM-HIGH results are not surprising when viewed through a particle lens.

Otvos JD.

J Clin Lipidol. 2011 Sep-Oct;5(5):368-70. doi: 10.1016/j.jacl.2011.06.012. Epub 2011 Jun 28. No abstract available.

PMID:
21981836
[PubMed - indexed for MEDLINE]
13.

What does the future hold for niacin as a treatment for hyperlipidaemia and cardiovascular disease?

Ahmed MH.

J Cardiovasc Med (Hagerstown). 2010 Nov;11(11):858-60. doi: 10.2459/JCM.0b013e32833dadc3.

PMID:
20686417
[PubMed - indexed for MEDLINE]
14.

[Statins (HMG-CoA reductase inhibitors), cholesterol and stroke].

Marta-Moreno J, Echeandia C, Oliveros-Cid A, Figuerola A, Mola S.

Rev Neurol. 1998 Nov;27(159):827-30. Review. Spanish.

PMID:
9859160
[PubMed - indexed for MEDLINE]
15.

Modification of high-density lipoprotein cholesterol in the management of cardiovascular risk.

Koeller J, Talbert RL.

Pharmacotherapy. 2002 Oct;22(10):1266-77. Review.

PMID:
12389877
[PubMed - indexed for MEDLINE]
16.

Advances in the understanding and management of dyslipidemia: using niacin-based therapies.

Ito MK.

Am J Health Syst Pharm. 2003 Jul 1;60(13 Suppl 2):S15-21; quiz S25.

PMID:
12901026
[PubMed - indexed for MEDLINE]
17.

Niacin-ER/statin combination for the treatment of dyslipidemia: focus on low high-density lipoprotein cholesterol.

Chrysant SG, Ibrahim M.

J Clin Hypertens (Greenwich). 2006 Jul;8(7):493-9; quiz 500-1. Review.

PMID:
16849903
[PubMed - indexed for MEDLINE]
18.

Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.

Amarenco P, Goldstein LB, Callahan A 3rd, Sillesen H, Hennerici MG, O'Neill BJ, Rudolph AE, Simunovic L, Zivin JA, Welch KM; SPARCL Investigators.

Atherosclerosis. 2009 Jun;204(2):515-20. doi: 10.1016/j.atherosclerosis.2008.09.008. Epub 2008 Sep 18.

PMID:
18962621
[PubMed - indexed for MEDLINE]
19.

Choice of lipid-regulating drugs.

[No authors listed]

Med Lett Drugs Ther. 2001 May 28;43(1105):43-8. No abstract available.

PMID:
11378632
[PubMed - indexed for MEDLINE]
20.

Therapies aim to boost "good" cholesterol.

Mitka M.

JAMA. 2008 Feb 6;299(5):509-10. doi: 10.1001/jama.299.5.509. No abstract available.

PMID:
18252876
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk